Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 27 January 2024 31 January 2025 31 January 2025 15446423 Dr Sarah Al-Bachari iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15446423 2024-01-26 15446423 2025-01-31 15446423 2024-01-27 2025-01-31 15446423 frs-core:CurrentFinancialInstruments 2025-01-31 15446423 frs-bus:PrivateLimitedCompanyLtd 2024-01-27 2025-01-31 15446423 frs-bus:FilletedAccounts 2024-01-27 2025-01-31 15446423 frs-bus:Micro-entities 2024-01-27 2025-01-31 15446423 frs-bus:AuditExempt-NoAccountantsReport 2024-01-27 2025-01-31 15446423 frs-bus:Director1 2024-01-27 2025-01-31
Registered number: 15446423
SAB Medical Services Limited
Financial Statements
For The Year Ended 31 January 2025
Balance Sheet
Registered number: 15446423
2025
£
Fixed assets 2,464
Current assets 15,549
Creditors: Amounts Falling Due Within One Year (3,937 )
NET CURRENT ASSETS 11,612
TOTAL ASSETS LESS CURRENT LIABILITIES 14,076
Accruals and deferred income (600 )
NET ASSETS 13,476
CAPITAL AND RESERVES 13,476

Notes

1. General Information
SAB Medical Services Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15446423 . The registered office is 56 Collins Drive, Ruislip, HA4 9EN.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Sarah Al-Bachari
Director
19 September 2025